Showing results (531-540 of 757) with videos related to

Sort By:
Pageof 76
Cardiovascular Research|May 30, 2023
Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal AssociationCarmine Zoccali, Francesca Mallamaci, Marcin Adamczak, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 18, 2026
The evolution of symptom burden in older men and women with advanced CKDNicholas C Chesnaye, Jenny Wrackefeldt, Fergus J Caskey, et al.
Diabetes Research and Clinical Practice|May 24, 2019
CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzleGuntram Schernthaner, Christoph Wanner, Dubravka Jurišić-Eržen, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|April 28, 2023
Differential Prognostic Utility of Adiposity Measures in Chronic Kidney DiseaseVladimir Cejka, Stefan Störk, Jennifer Nadal, et al.
Clinical Kidney Journal|April 4, 2022
The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney diseaseZiad A Massy, Nicholas C Chesnaye, Islam Amine Larabi, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|February 23, 2013
Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM)Juan Jesús Carrero, Peter Stenvinkel, Lilian Cuppari, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2023
Clinical and patient-reported trajectories at end-of-life in older patients with advanced CKDNicholas C Chesnaye, Fergus J Caskey, Friedo W Dekker, et al.
European Heart Journal|April 22, 2025
Incident hyperkalaemia risk model in chronic kidney disease and diabetes: the FIDELITY programmeJoão Pedro Ferreira, Stefan D Anker, Biff F Palmer, et al.
Biochemical and Biophysical Research Communications|October 22, 2021
Protective effects of spironolactone on vascular calcification in chronic kidney diseaseFabian Hammer, Salvatore S Buehling, Jaber Masyout, et al.
Kidney International|September 1, 2023
Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney diseaseKam Wa Chan, J David Smeijer, Meir Schechter, et al.
Pageof 76